From humble beginnings as BioMedical Asia in 2008, BioPharma Asia served over 22,000 attendees over its first 9 years. But fast forward 10 years later and the things look markedly different.
Asia is more than just a pharma sales & marketing destination, and it’s more than a cheaper manufacturing hub. Now, it leads the way with pharma innovation and R&D.
Home to ecosystems ripe for innovation, including biotech hubs in Singapore, China and Korea, Asia is taking us to new frontiers in cutting-edge research and creating exciting breakthrough therapies. So we thought it was time for a change too.
Welcome to Phar-East.
Building on the success of our global life sciences portfolio, we’re bringing you a greatest hits event.
Across 2 days, we’ll be exploring 11 of the most exciting pharma areas in Asia: immunotherapy, vaccines, precision medicine, cell & gene therapy, biodata, orphan drugs, partnering, commercialisation & market access, antibodies, biosimilars and biotech innovation.
It’s our biggest agenda ever, showcasing the very best in Asian pharma excellence.
It’s where big pharma and biotech, regulators and payers, solution providers and technology leaders all come together to build new relationships, cement existing partnerships and chart the path forward in Asia’s life sciences industry.
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Chinese New Year 2020: Year of the Rat
On January 19, the domestic phthalic anhydride market ran smoothly
Toluene Guide: January 19 domestic toluene market trend is stable
The domestic pure benzene market fluctuated on January 19
On January 19, the domestic styrene market was relatively strong
Methanol Guide: morning analysis of methanol market on January 17